Cytosorbents
CTSO
#9825
Rank
C$63.38 M
Marketcap
C$1.01
Share price
-1.20%
Change (1 day)
-18.93%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -C$16.38 Million

According to Cytosorbents's latest financial reports the company's current earnings are C$36.1 Million. In 2024 the company made an earning of -C$30.82 Million, an increase over its 2023 earnings that were of -C$40.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$16.38 Million-46.86%
2024 -C$30.82 Million-23.97%
2023 -C$40.54 Million-13.52%
2022 -C$46.88 Million34.04%
2021 -C$34.97 Million182.17%
2020 -C$12.4 Million-55.97%
2019 -C$28.15 Million14.17%
2018 -C$24.65 Million95.14%
2017 -C$12.64 Million-22.32%
2016 -C$16.27 Million39.1%
2015 -C$11.7 Million-12.89%
2014 -C$13.42 Million89%
2013 -C$7.11 Million26.65%
2012 -C$5.61 Million-26.02%
2011 -C$7.58 Million-288.45%
2010 C$4.02 M-4.17%
2009 C$4.19 M-287.19%
2008 -C$2.25 Million-47.12%
2007 -C$4.24 Million41.78%
2006 -C$3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
C$76.73 M-585.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
C$1.10 B-7,057.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
C$4.52 B-28,683.67%๐Ÿ‡บ๐Ÿ‡ธ USA